An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cresco Labs, a leader in branded cannabis products, will report its first quarter 2024 financial results on May 15, 2024. The company will discuss key business highlights during a conference call and webcast.
Cresco Labs, leader nei prodotti di cannabis di marca, comunicherà i risultati finanziari del primo trimestre del 2024 il 15 maggio 2024. L'azienda discuterà dei principali punti salienti dell'attività durante una conferenza telefonica e un webcast.
Cresco Labs, líder en productos de cannabis de marca, informará sobre sus resultados financieros del primer trimestre de 2024 el 15 de mayo de 2024. La compañía discutirá los aspectos más destacados del negocio durante una llamada de conferencia y una transmisión web.
브랜드 대마초 제품의 선두 주자인 크레스코 랩스는 2024년 5월 15일에 2024년도 1분기 재무 결과를 보고할 예정입니다. 회사는 컨퍼런스 콜과 웹캐스트 동안 주요 사업 하이라이트에 대해 논의할 것입니다.
Cresco Labs, leader dans les produits de cannabis de marque, publiera ses résultats financiers pour le premier trimestre 2024 le 15 mai 2024. L'entreprise discutera des points saillants de l'activité lors d'une conférence téléphonique et d'une webdiffusion.
Cresco Labs, ein führender Anbieter von Marken-Cannabisprodukten, wird am 15. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 vorlegen. Das Unternehmen wird während eines Telefonkonferenzgesprächs und eines Webcasts wichtige Geschäftshighlights besprechen.
Positive
None.
Negative
None.
CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the first quarter ended March 31st, 2024 on Wednesday, May 15th, 2024 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs First Quarter 2024 Earnings Conference Call
Date: Wednesday, May 15th, 2024
Time: 8:30 am EST
Webcast: LINK
Dial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 897519
Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.
cresco labs llc is an illinois medical cannabis company, licensed to develop and operate medical cannabis cultivation centers in police districts 5, 9 and 21, according to illinois’ office of the governor. cresco labs exceeded the state’s rigorous qualifying standards, receiving the highest scores of any cultivation center applicant to obtain three of 18 total awarded cultivation licenses as part of the illinois medical cannabis pilot program.